Clinical and Translational Radiation Oncology

Papers
(The H4-Index of Clinical and Translational Radiation Oncology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness144
4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience64
The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts61
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac50
Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment47
A review of the role of MRI in diagnosis and treatment of early stage lung cancer34
The technical design and concept of a PET/CT linac for biology-guided radiotherapy33
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator27
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance27
Influence of dose-averaged linear energy transfer on tumour control after carbon-ion radiation therapy for pancreatic cancer25
Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine24
Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry23
Whole Brain Irradiation or Stereotactic RadioSurgery for five or more brain metastases (WHOBI-STER): A prospective comparative study of neurocognitive outcomes, level of autonomy in daily activities a22
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer21
Radiomic biomarkers of tumor immune biology and immunotherapy response20
Stability analysis of CT radiomic features with respect to segmentation variation in oropharyngeal cancer20
CDK 4/6 inhibitors combined with radiotherapy: A review of literature20
Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy18
Incidence and dose-volume relationship of radiation pneumonitis after concurrent chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer18
0.05450701713562